James R. Burton

2.8k total citations · 1 hit paper
48 papers, 1.9k citations indexed

About

James R. Burton is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, James R. Burton has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 27 papers in Surgery and 22 papers in Epidemiology. Recurrent topics in James R. Burton's work include Liver Disease and Transplantation (22 papers), Liver Disease Diagnosis and Treatment (21 papers) and Organ Transplantation Techniques and Outcomes (19 papers). James R. Burton is often cited by papers focused on Liver Disease and Transplantation (22 papers), Liver Disease Diagnosis and Treatment (21 papers) and Organ Transplantation Techniques and Outcomes (19 papers). James R. Burton collaborates with scholars based in United States, Canada and Philippines. James R. Burton's co-authors include Gregory T. Everson, Hugo R. Rosen, Paul Y. Kwo, Robert S. Brown, Norah A. Terrault, Jean C. Emond, Johnny C. Hong, Julie K. Heimbach, Hugo E. Vargas and Sarwa Darwish Murad and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

James R. Burton

44 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers

2012 351 citations Sarwa Darwish Murad, W. Ray Kim et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James R. Burton United States	20	1.4k	950	913	238	207	48	1.9k
Fédérica Dondero France	23	874 0.6×	469 0.5×	876 1.0×	102 0.4×	212 1.0×	55	1.4k
Marc Deschênes Canada	29	1.7k 1.2×	1.7k 1.8×	845 0.9×	191 0.8×	50 0.2×	88	2.6k
Christopher R. Shackleton United States	21	1.6k 1.1×	498 0.5×	1.6k 1.8×	163 0.7×	338 1.6×	38	2.0k
J.F. Trotter United States	19	985 0.7×	530 0.6×	859 0.9×	75 0.3×	233 1.1×	43	1.4k
Les Lilly Canada	23	1.3k 0.9×	901 0.9×	822 0.9×	83 0.3×	208 1.0×	45	1.7k
José Castellote Spain	27	1.3k 0.9×	1.1k 1.1×	882 1.0×	457 1.9×	40 0.2×	88	2.2k
Federico Villamil United States	19	1.9k 1.4×	1.5k 1.6×	923 1.0×	127 0.5×	193 0.9×	47	2.5k
Mitchell L. Shiffman United States	24	2.7k 1.9×	1.8k 1.9×	1.8k 2.0×	428 1.8×	679 3.3×	43	3.6k
AK Burroughs United Kingdom	22	1.6k 1.2×	1.5k 1.6×	819 0.9×	204 0.9×	26 0.1×	80	2.3k
Atif Zaman United States	26	1.5k 1.1×	1.4k 1.5×	1.1k 1.2×	174 0.7×	43 0.2×	72	2.4k

Countries citing papers authored by James R. Burton

Since Specialization

Citations

This map shows the geographic impact of James R. Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Burton more than expected).

Fields of papers citing papers by James R. Burton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Burton. The network helps show where James R. Burton may publish in the future.

Co-authorship network of co-authors of James R. Burton

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Burton. A scholar is included among the top collaborators of James R. Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Burton. James R. Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kriss, Michael, et al.. (2025). Liver transplantation for colorectal cancer with liver metastases. The Oncologist. 30(1). 6 indexed citations

Burton, James R., et al.. (2025). Cholate Clearance: Improving the Assessment of Liver Health Compared to Current Liver Tests. Gastro Hep Advances. 5(2). 100814–100814.

Schold, Jesse D., Sumit Mohan, Whitney E. Jackson, et al.. (2023). Differential in Kidney Graft Years on the Basis of Solitary Kidney, Simultaneous Liver–Kidney, and Kidney-after-Liver Transplants. Clinical Journal of the American Society of Nephrology. 19(3). 364–373. 2 indexed citations

Moore, Hunter B., Yanik J. Bababekov, James J. Pomposelli, et al.. (2022). The vexing triad of obesity, alcohol, and coagulopathy predicts the need for multiple operations in liver transplantation. The American Journal of Surgery. 224(1). 69–74. 2 indexed citations

Yoeli, Dor, Whitney E. Jackson, Michael Wachs, et al.. (2021). Challenging the Traditional Paradigm of Supply and Demand in Pediatric Liver Transplantation Through Nondirected Living Donation: A Case Series. Liver Transplantation. 27(10). 1392–1400. 6 indexed citations

Perrillo, Robert P., James R. Burton, & Lindsey Westbrook. (2021). Herbal hepatitis due to use of alternative medicines for Lyme disease. Baylor University Medical Center Proceedings. 35(1). 104–105. 1 indexed citations

Burton, James R., Norah A. Terrault, David S. Goldberg, et al.. (2019). Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation. Transplantation. 104(3). 476–481. 19 indexed citations

Kalra, Avash, James R. Burton, & Lisa Forman. (2018). Pro: Steroids Can Be Withdrawn After Transplant in Recipients With Autoimmune Hepatitis. Liver Transplantation. 24(8). 1109–1112. 8 indexed citations

Kaplan, Jeffrey, et al.. (2017). Adequacy of transjugular liver biopsy compared with percutaneous liver biopsy for staging fibrosis. Journal of Vascular and Interventional Radiology. 28(2). S205–S205.

10.

Verna, Elizabeth C., Varun Saxena, James R. Burton, et al.. (2015). Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease. Transplantation. 99(8). 1644–1651. 12 indexed citations

11.

Olthoff, Kim M., Abigail R. Smith, Michaël Abécassis, et al.. (2015). Defining Long-term Outcomes With Living Donor Liver Transplantation in North America. Annals of Surgery. 262(3). 465–475. 123 indexed citations

12.

Kwo, Paul Y., Parvez Mantry, Eoin Coakley, et al.. (2014). An Interferon-free Antiviral Regimen for HCV after Liver Transplantation. New England Journal of Medicine. 371(25). 2375–2382. 297 indexed citations

13.

Burton, James R., Jacqueline G. O’Leary, Elizabeth C. Verna, et al.. (2014). A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy. Journal of Hepatology. 61(3). 508–514. 59 indexed citations

14.

Verna, Elizabeth C., James R. Burton, Jacqueline G. O’Leary, et al.. (2013). 23 A MULTICENTER STUDY OF PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS: REPORT FROM THE CRUSH-C GROUP. Journal of Hepatology. 58. S10–S11. 18 indexed citations

15.

Biggins, Scott W., James F. Trotter, Jane Gralla, et al.. (2013). Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. Journal of Hepatology. 58(5). 969–976. 13 indexed citations

16.

Murad, Sarwa Darwish, W. Ray Kim, Denise M. Harnois, et al.. (2012). Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers. Gastroenterology. 143(1). 88–98.e3. 351 indexed citations breakdown →

17.

Burton, James R. & Gregory T. Everson. (2012). Management of the Transplant Recipient with Chronic Hepatitis C. Clinics in Liver Disease. 17(1). 73–91. 18 indexed citations

18.

Shah, Raj J., et al.. (2011). Mo1461 Biliary-Enteric Anastomotic Stricturoplasty Using Overtube-Assisted Enteroscopy ERCP in Patients With Long Limb Surgical Biliary Bypass. Gastrointestinal Endoscopy. 73(4). AB353–AB353. 2 indexed citations

19.

Benson, Alexander B., James R. Burton, Gregory L. Austin, et al.. (2010). Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transplantation. 17(2). 149–158. 97 indexed citations

20.

Burton, James R. & Hugo R. Rosen. (2006). Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transplantation. 12(Supplement 2). S38–S47. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact